|
|
|
Weekly News Digest
 |
April 28, 2008 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITI’s Twitter account: @ITINewsBreaks.
CLICK HERE to view more Weekly News Digest items.
|
New Enhancements Broaden Rightsphere’s Reach
Rightsphere, the rights advisory and management tool from Copyright Clearance Center (CCC; www.copyright.com), recently added several enhancements to help customers manage complex rights and licenses with speed and precision. The CCC credits corporate information managers and librarians with supplying the necessary input to help drive these changes to the marketplace.The latest round of enhancements include the following innovations: - Date-delimited rights so administrators can specify rights for a certain period (i.e., from 1978 to 2003) or for a relative period (i.e., for the past 12 months)
- More preloaded rights categories to give administrators more flexibility and accuracy for their licensing agreements, including sharing content in PowerPoint presentations or creating posters that feature excerpts from copyrighted articles
- Company policy statements on content use for end users when they check for permissions
- An enhanced user interface for Rightsphere’s Agreement Manager that records the rights and terms for licensing agreements
Since Rightsphere was first launched in 2006, global leaders in the pharmaceutical, aerospace, and consumer goods industries have adopted the web-based application. As a result, general counsels, information managers, and corporate librarians can now automate rights management on a granular level to maximize the value of site licenses and share nuances of corporate content use policies at the point of use to staffers worldwide. As a hosted service, Rightsphere provides customers such as AstraZeneca, Eli Lilly, and Pfizer with automatic upgrades as enhancements are added. Source: Copyright Clearance Center
Send correspondence concerning the Weekly News Digest to NewsBreaks Editor
Brandi Scardilli
|
